Literature DB >> 8992489

Endothelial permeability under physiological and pathological conditions.

A Tedgui1.   

Abstract

Due to their special position at the tissue-blood interface, the endothelial cells are endowed with two mechanisms for handling plasma molecules: one, receptor-mediated endocytosis, which supplies nutrients for the cell's own metabolic needs; the other, direct transendothelial transport of material from plasma to the intima of arteries. Under normal physiological conditions, the latter transendothelial pathway is far more important than the endocytic one. Routes for exchange of both small and large plasma molecules include the clefts between adjacent endothelial cells (paracellular) and plasmalemmal vesicles. Paracellular transport is restricted to molecules smaller than 4 nm in diameter, and is the pathway for water filtration. Larger molecules, as large as 30 nm in diameter, are transported through plasmalemmal vesicles. Changes in endothelial permeability occur during inflammation, hypertension or diabetes.

Entities:  

Mesh:

Year:  1996        PMID: 8992489     DOI: 10.1016/s0952-3278(96)90077-0

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

1.  Effect of low shear stress on permeability and occludin expression in porcine artery endothelial cells.

Authors:  Brian S Conklin; Raymond P Vito; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

2.  Adaptive response of vascular endothelial cells to an acute increase in shear stress frequency.

Authors:  Ji Zhang; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-12       Impact factor: 4.733

3.  Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanisms.

Authors:  Graciela Krikun; Jordan Trezza; Jeff Shaw; Mizan Rahman; Seth Guller; Vikki M Abrahams; Charles J Lockwood
Journal:  Am J Reprod Immunol       Date:  2012-06-04       Impact factor: 3.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.